With limited partners turning cautious as the global recession leaves them with less surplus cash to invest, Yes Bank will…
Goldman Sachs plans to exit from its private equity investment in Punjab-based food major, Cremica. Goldman Sachs had acquired 10%…
Aditya Birla Private Equity, the private equity arm of the Aditya Birla Group, is betting big in the business services…
Pharmaceuticals major Johnson & Johnson is likely to face a setback in the Indian babycare products market if the 5.5-lakh…
Of course pubs routinely spring surprises on you, but sometimes these are of the instructive sort.
Domestic pharmaceutical revenue stands at $6.2 bn, while that of Japan where population is lesser, is at $60 bn.
Though the slowdown in domestic as well the global markets will cast a shadow over the margins of the major…
Beam Global Spirits & Wine Inc, the fourth-largest premium spirits company in the world, is bringing its renowned brands, such…
There’s a bright side to the dip in private equity and venture capital investments in Indian companies in 2008; investments…
The Indian liquor industry, which claimed to be insulated from the financial crunch, seems to have developed pessimism over their…
The Indian liquor industry witnessed a cache of premium alcohol brand launches in the year 2008. The brands vary from…
The media and entertainment sector has witnessed a number of private equity deals in the month of December, despite a…
Bacardi Ltd, the name synonymous with white spirits, is setting its eye on the Indian whisky market with the launch…
Wine manufacturers in Maharashtra have come together to challenge a state excise department notice demanding payment of the entire dues…
The liquor sector, unlike other sectors, is not witnessing a slowdown, insulated as it is from the current economic crisis.…
Rabo Equity Advisors, the private equity arm of Rabobank, is all set to sign its first investment deal this month.
US drug major Eli Lilly, continuing its fight against the generic launch of its second-largest selling drug, Cymbalta, sued Sun…
It?s business as usual for Indian pharmaceutical firms that lead the patent litigations chart for bettering their prospects in the…
